The Platinum Study

2,000+Patients enrolled

37Median age of patients

13Participating sites

The latest research

The Platinum Study Group is following more than 2,000 testicular cancer survivors—the largest clinical cohort of germ cell cancer survivors worldwide. A key focus is examining the role of genetic variants in toxicities, especially hearing-related issues, to identify high-risk subgroups.

Newly published:

Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments. Ear Hear. 2022 Jan 21. PMID: 35067571.

This study is a critical part of my life’s mission: to decrease the cost of the cure for cancer survivors.

Lois Travis, MD — Principal Investigator


Support Our Research